4//SEC Filing
ADURO BIOTECH, INC. 4
Accession 0001209191-17-044232
CIK 0001435049operating
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 7:10 PM ET
Size
20.6 KB
Accession
0001209191-17-044232
Insider Transaction Report
Form 4
Dubensky Thomas W.
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2017-07-03$0.52/sh+11,800$6,136→ 51,700 total - Sale
Common Stock
2017-07-03$11.02/sh−11,800$130,028→ 39,900 total - Sale
Common Stock
2017-07-06$11.23/sh−4,512$50,673→ 39,900 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-07-06−4,512→ 13,571 totalExercise: $0.52Exp: 2021-10-23→ Common Stock (4,512 underlying) - Sale
Common Stock
2017-07-05$11.46/sh−33,688$385,936→ 39,900 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-07-05−33,688→ 18,083 totalExercise: $0.52Exp: 2021-10-23→ Common Stock (33,688 underlying) - Exercise/Conversion
Common Stock
2017-07-06$0.52/sh+4,512$2,346→ 44,412 total - Exercise/Conversion
Common Stock
2017-07-05$0.52/sh+33,688$17,518→ 73,588 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-07-03−11,800→ 51,771 totalExercise: $0.52Exp: 2021-10-23→ Common Stock (11,800 underlying)
Footnotes (5)
- [F1]The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2017.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.80 to $11.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.90 to $11.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.10 to $11.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F5]The shares subject to the Option were fully vested as of September 1, 2015.
Documents
Issuer
ADURO BIOTECH, INC.
CIK 0001435049
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001435049
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 7:10 PM ET
- Size
- 20.6 KB